The global in vitro fertilization test market size is expected to hit around US$ 2.8 billion by 2030 and is expected to grow at a noteworthy CAGR of 6.1% from 2020 to 2030.
The global in vitro fertilization test market size is expected to hit around US$ 2.8 billion by 2030 and is expected to grow at a noteworthy CAGR of 6.1% from 2020 to 2030. The surge in inclination toward delayed pregnancies, number of fertility clinics across the globe, and fertility tourism is anticipated to drive the global in vitro fertilization test market.
Solutions for Medically Complicated Patients, Simple Metrics Improve Clinical Numbers
The IVF procedure is potentially challenging in patients with pre-existing medical conditions. The IVF is a complex series of procedures involving ovarian stimulation, oocyte retrieval, and laboratory techniques to achieve maximal rates of fertilization, embryo development, and embryo transfer (ET). In order to ensure the faith of medically complicated patients, healthcare professionals are offering specific treatments to hypertension patients or patients with cardiovascular diseases. These include antihypertensive medications and regular cardiology consultation, respectively, to improve clinical outcomes in the in vitro fertilization test market.
Full Report is Ready | Get the sample copy of report@ https://www.visionresearchreports.com/report/sample/38159
Describing medical outcomes from in vitro fertilization test has been an evolving challenge throughout the world. This has led to the importance of three simple metrics that provide a transparent and highly accurate summary of IVF tests. These include the probability of having no embryo available to transfer, sustained implantation rate, and the number of supernumerary embryos cryopreserved during the cycle.
Preference for PGT-A to Improve Implantation Rates, Reduce Miscarriages
Based on claims of better live birth and reduced miscarriage rates, the technique of the preimplantation genetic testing for aneuploidy (PGT-A) in association with IVF has increasingly grown in the U.S. Companies in developing economies of South Asia are taking cues from such findings to improve their medical services in hospitals and fertility clinics.
PGT-A in a single trophectoderm biopsy at blastocyst stage reliably determines whether an embryo is euploid or chromosomal abnormal. PGT-A is gaining recognition in the in vitro fertilization test market for improving implantation rates and reducing miscarriages. This strategy has now become a routine add-on for IVF to determine whether human embryos are to be clinically utilized or disposed.
Preimplantation Genetic Testing to Dominate Global Market
In terms of test type, the global in vitro fertilization test market has been classified into sperm aneuploidy test, genetic compatibility test, preimplantation genetic testing, endometrial receptivity analysis, noninvasive prenatal testing, and others. The preimplantation genetic testing (PGD) segment is expected to dominate the global in vitro fertilization test market from 2021 to 2031. The usage of PGD for chromosomal aberrations, aneuploidy screening, gender selection, single gene disorder, HLA typing, and X-linked diseases has been increasing rapidly due to benefits associated with better pregnancy rate and birth of a healthy child. Aneuploidy screening using PGD has eased the method of detecting the risk of a syndrome caused due to variation in the number of chromosomes. This is expected to drive the segment during the forecast period.
Full Report is Ready | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38159
Fertility Clinics to be Major End Users
Based on end user, the global in vitro fertilization test market has been divided into fertility clinics, hospitals, and others. The fertility clinics segment is likely to account for a significant share of the global in vitro fertilization test market by 2031. Rise in fertility tourism and insurance coverage and government initiatives in registration of fertility clinics to provide safe and high quality IVF treatments are likely to fuel the growth of the fertility clinics segment.
Regional Outlook
In terms of region, the global in vitro fertilization test market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa)
The report provides market size and forecast for each region and country/sub-region from 2017 to 2030. Compound annual growth rate (CAGR) of each of these regions and countries have also been provided for the forecast period from 2021 to 2030, considering 2020 as the base year. The in vitro fertilization test market study also covers the competitive scenario in these regions.
Overview
- This report analyzes the current and future prospects of the global in vitro fertilization test market. Increase in population with infertility issues, in vitro fertilization success rates, inclination toward delayed pregnancies, number of fertility clinics across the globe, and fertility tourism is a key factor projected to fuel the growth of the global in vitro fertilization test market during the forecast period.
- The report provides an elaborate executive summary, which comprises a snapshot of the various segments of the global in vitro fertilization test market. The report also provides information and data analysis of the global in vitro fertilization test market about segments based on test type, end user, and region.
- The overview section of the report provides detailed qualitative analysis of drivers and restraints impacting the global in vitro fertilization test market, along with opportunities in the global market
- Additionally, the global in vitro fertilization test market report includes company profiles and competitive matrix, which provide data about their businesses, product portfolios, and competitive landscape in the global in vitro fertilization test market
- The report includes data analysis on the in vitro fertilization test market attractiveness by region and segments
- The last section of the report provides quantitative and qualitative analysis on market share of key players operating in the global in vitro fertilization test market. It elaborates on the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global in vitro fertilization test market.
Key Players
The report provides profiles of leading players operating in the global in vitro fertilization test market. These include CooperSurgical, Inc., Esco Micro Pte Ltd., FUJIFILM Irvine Scientific, Hamilton Thorne, Inc., Vitrolife AB, IVFtechApS, Nidacon International AB, Igenomix, Thermo Fisher Scientific, Cook, GeneaBiomedx, FertiPro N.V, Kitazato Corporation, PerkinElmer, Inc., Natera, Takara Bio, Inc., iGLS, and CiceroDx.
Market Segmentation
- By Test Type
- Sperm Aneuploidy Test
- Genetic Compatibility Test
- Preimplantation Genetic Testing
- Endometrial Receptivity Analysis
- Noninvasive Prenatal Testing
- Others
- By End User
- Fertility Clinics
- Hospitals
- Others
- By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Full Report is Ready | Buy this Premium Research Report@ https://www.visionresearchreports.com/report/cart/38159
You can place an order or ask any questions, please feel free to contact at sales@visionresearchreports.com | +1 9197 992 333